CLRB - Cellectar Biosciences misses by $0.26 May, 06 2019 08:21 AM Cellectar Biosciences Inc. Cellectar Biosciences (NASDAQ:CLRB): Q1 GAAP EPS of -$0.76 misses by $0.26.Cash and cash equivalents of $10.48MPress ReleaseMore news on: Cellectar Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, ,